Apoptosis-inducing factor deficiency induces early mitochondrial degeneration in brain followed by progressive...

Area of Science:

• Neuroscience
• Mitochondrial Biology
• Genetics

Background:

• Apoptosis-inducing factor (AIF) deficiency impairs oxidative phosphorylation.
• Harlequin mice exhibit downregulated AIF and severe mitochondrial complex I (CI) deficiency.
• This suggests Harlequin mice could model oxidative phosphorylation disorders.

Purpose of the Study:

• To investigate the whole brain phenotype of Harlequin mice.
• To determine if Harlequin mice are a suitable model for CI-deficient disorders.
• To compare the Harlequin mouse phenotype to human CI deficiencies.

Main Methods:

• Investigated the whole brain of Harlequin mice throughout disease progression.
• Assessed neurodegeneration, glial activation, and vascular proliferation.
• Examined mitochondrial morphology in various cell types.

Main Results:

• Neurodegeneration extended beyond the cerebellum to thalamic, striatal, and cortical regions.
• Significant astroglial and microglial activation occurred in affected brain areas.
• Degenerating mitochondria were observed early, even in non-dying cells, indicating primary mitochondrial injury.
• The observed phenotype was broader than previously reported and showed similarities to human neurodegenerative mitochondriopathies.

Conclusions:

• AIF deficiency in Harlequin mice leads to early mitochondrial damage and progressive, multifocal neuropathology.
• The Harlequin mouse model exhibits a broader brain phenotype than initially recognized.
• This model closely resembles histopathological features of human neurodegenerative mitochondriopathies linked to CI deficiency.